A unique cell surface antigen identifying lymphoid malignancies of B cell origin.

A monoclonal antibody (anti-B1) specific for a unique B cell surface differentiation antigen was used to characterize the malignant cells from patients with leukemias or lymphomas. All tumor cells from patients with lymphomas or chronic lymphocytic leukemias, bearing either monoclonal kappa lambda l...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	J Clin Invest
Hauptverfasser:	Nadler, L M, Ritz, J, Hardy, R, Pesando, J M, Schlossman, S F, Stashenko, P
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Clinical Investigation 1981
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371580/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6969730/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110005
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!